Ligand validation:8DDM

K36: (1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid

K36 is a Ligand Of Interest in 8DDM designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8DDM_K36_A_401	41%	8%	0.183	0.919	3	1.59	8	7	0	0	88%	0.8788
7CB7_K36_A_402	82%	7%	0.076	0.953	3.42	1.51	9	6	0	0	88%	0.413
7D1M_K36_A_401	81%	70%	0.091	0.963	0.63	0.52	1	1	1	1	88%	0.7455
8D4M_K36_A_401	73%	9%	0.089	0.937	3.02	1.48	9	6	0	0	88%	0.8788
7K0G_K36_A_401	72%	28%	0.103	0.949	1.52	1.35	4	4	0	0	88%	0.4394
8D4K_K36_A_401	72%	9%	0.096	0.941	3.03	1.51	8	6	1	0	88%	0.8788
4DCD_K36_A_202	78%	31%	0.08	0.942	1.26	1.49	3	6	0	1	88%	0.8788
3UR9_K36_B_203	73%	9%	0.072	0.952	2.09	2.32	4	9	0	1	70%	0.697

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.